CS logo
small CS logo
Medicity S.A.S.

Bucaramanga, Colombia
Health in Bucaramanga
Cra. 34 #46-50, Bucaramanga, Santander

About Medicity S.A.S.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
5
Galapagos NV
3
Janssen Research & Development, LLC
3
R-Pharm International, LLC
3
Genentech, Inc.
2
Actelion
1
Astellas Pharma Inc
1
Boston Pharmaceuticals
1
Bristol-Myers Squibb
1
Celgene
1
Total Rows: 10

Clinical Trials at Medicity S.A.S.


During the past decade, Medicity S.A.S. conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 15 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 12 clinical trials were completed. i.e. 600% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years115533110022001111004433Started TrialsCompleted Trails2016201720182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis
2009-06-18
2011-02-18
Completed
195
PF-00489791 For The Treatment Of Raynaud's
2010-08-04
2011-05-31
Completed
243
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
2010-09-01
2016-06-01
Terminated
2,867
A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis
2010-11-01
2013-01-01
Completed
1,101
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
2011-12-01
2013-11-01
Completed
289
A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate
2012-07-06
2014-02-11
Completed
379
Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)
2013-07-17
2015-05-14
Completed
599
Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2)
2013-10-08
2015-05-29
Completed
287

Rows per page:

1–21 of 21

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Medicity S.A.S." #1 sponsor was "Pfizer" with 5 trials, followed by "Galapagos NV" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "R-Pharm International, LLC" with 3 trials sponsored and "Genentech, Inc." with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Medicity S.A.S." #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Mene Research" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 5Pfizer: 5Galapagos NV: 3Galapagos NV: 3Janssen Research &Development, LLC: 3Janssen Research &Development, LLC: 3R-Pharm International, LLC: 3R-Pharm International, LLC: 3Genentech, Inc.: 2Genentech, Inc.: 2Actelion: 1Actelion: 1Astellas Pharma Inc: 1Astellas Pharma Inc: 1Boston Pharmaceuticals: 1Boston Pharmaceuticals: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Celgene: 1Celgene: 1

Created with Highcharts 11.1.0Top CollaboratorsOCT Clinical Trials: 3OCT Clinical Trials: 3Quintiles, Inc.: 2Quintiles, Inc.: 2Gilead Sciences: 1Gilead Sciences: 1IQVIA Pvt. Ltd: 1IQVIA Pvt. Ltd: 1Mene Research: 1Mene Research: 1

Clinical Trials Conditions at Medicity S.A.S.


According to Clinical.Site data, the most researched conditions in "Medicity S.A.S." are "Rheumatoid Arthritis" (7 trials), "Systemic Lupus Erythematosus" (5 trials), "Lupus Erythematosus, Systemic" (3 trials), "Psoriasis" (2 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Medicity S.A.S." in a lesser frequency.

Clinical Trials Intervention Types at Medicity S.A.S.


Most popular intervention types in "Medicity S.A.S." are "Drug" (21 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "GDC-0853" (2 trials), "GLPG0634" (2 trials), "Nipocalimab" (2 trials) and "Adalimumab 40mg q2w" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Medicity S.A.S.


The vast majority of trials in "Medicity S.A.S." are 21 trials for "All" genders.

Clinical Trials Status at Medicity S.A.S.


Currently, there are NaN active trials in "Medicity S.A.S.". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Medicity S.A.S., undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Medicity S.A.S., 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 13Phase 2: 13Phase 3: 8Phase 3: 8Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 15Completed: 15Terminated: 3Terminated: 3Recruiting: 2Recruiting: 2Active, not recruiting: 1Active, not recruiting: 1